Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co Days Payable Chart
Tianjin TEDA Biomedical Engineering Co Annual Data
HKSE:08189 vs CTVA, CF, MOS: Days Payable Comparison
For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin TEDA Biomedical Engineering Co Days Payable vs Agriculture Industry
Tianjin TEDA Biomedical Engineering Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co (HKSE:08189) has a Days Payable of 18.28 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. This is 27% below median its historical median of 24.96. Over the past decade, Tianjin TEDA Biomedical Engineering Co's Days Payable has ranged from 11.58 to 34.32. According to the industry distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #222 out of 245 companies in the Agriculture industry, placing it in the top 90.6%.
Is Tianjin TEDA Biomedical Engineering Co's Days Payable too high?
Tianjin TEDA Biomedical Engineering Co's current Days Payable of 18.28 is 27% below median its 10-year median of 24.96. Over the past 10 years, this metric has ranged from a low of 11.58 to a high of 34.32. The Agriculture industry median Days Payable is 71.49. Tianjin TEDA Biomedical Engineering Co's value of 18.28 is 74.4% below this industry median. Based on the distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #222 out of 245 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's Days Payable compare to CTVA and CF?
According to the Agriculture industry distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #222 out of 245 companies for Days Payable. This places Tianjin TEDA Biomedical Engineering Co in the lower half of its industry. The industry median Days Payable is 71.49. Tianjin TEDA Biomedical Engineering Co's value of 18.28 is 74.4% below this benchmark. Historically, Tianjin TEDA Biomedical Engineering Co's own Days Payable has ranged from 11.58 to 34.32 over the past decade. While the company's 10-year median is 24.96 vs. the industry median of 71.49, Tianjin TEDA Biomedical Engineering Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Agriculture company?
The median Days Payable among Agriculture companies is 71.49, based on 245 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tianjin TEDA Biomedical Engineering Co's current Days Payable of 18.28 is 74.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. For the Agriculture industry, the median Days Payable is 71.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tianjin TEDA Biomedical Engineering Co's current Days Payable is 18.28, which is 27% below median its own 10-year median of 24.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (HKSE:08189) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.19, compared to a current price of HK$0.26 — trading 34.2% above its estimated fair value. The current Days Payable is 18.28, which is 27% below median its 10-year median of 24.96 and 74.4% below the Agriculture industry median of 71.49. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (HKSE:08189), the current Days Payable is 18.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued.
The current stock price of HK$0.26 is trading 34.2% above its estimated GF Value™ of HK$0.19.
GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.
Key valuation signals for HKSE:08189:
Days Payable: 18.28 (27% below median its 10-year median of 24.96)
GF Value™: HK$0.19 vs. price of HK$0.26 (34.2% above fair value)
Industry Position: 74.4% below the Agriculture median (#222 of 245)
No single metric tells the full story. See the HKSE:08189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score
Get the complete analysis for HKSE:08189
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08189 has been successfully added to your 
